(2023) Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis: A case report. Clinical Case Reports. p. 4. ISSN 2050-0904
Full text not available from this repository.
Official URL: http://apps.webofknowledge.com/InboundService.do?F...
Abstract
Here, we present a case of relapsing-remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care. Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis.image
Item Type: | Article |
---|---|
Keywords: | alemtuzumab DMT epistaxis immune thromboctopenic purpura ITP MS multiple sclerosis RRMS General & Internal Medicine |
Page Range: | p. 4 |
Journal or Publication Title: | Clinical Case Reports |
Journal Index: | ISI |
Volume: | 11 |
Number: | 11 |
Identification Number: | https://doi.org/10.1002/ccr3.8143 |
ISSN: | 2050-0904 |
Depositing User: | خانم ناهید ضیائی |
URI: | http://eprints.mui.ac.ir/id/eprint/27223 |
Actions (login required)
![]() |
View Item |